Table 3.
Effects on mobility and secondary outcome measures at 12 and 18 months of follow up according to treatment. Values are mean (SD) unless stated otherwise
| Outcome measures | 12 month follow up
|
18 month follow up
|
|||||
|---|---|---|---|---|---|---|---|
| Home visits (n=129) | Usual care (n=123) | Adjusted difference* (95% CI) | Home visits (n=120) | Usual care (n=115) | Adjusted difference* (95% CI) | ||
| Mobility impairments | |||||||
| Mobility control (0 (favourable) to 12) | 5.1 (2.8) | 5.3 (2.7) | −0.0 (−0.6 to 0.5) | 5.5 (2.8) | 5.5 (2.7) | 0.0 (−0.6 to 0.6) | |
| Mobility range† (0 (favourable) to 10) | 2.0 (2.5) | 2.6 (3.0) | −0.1 (−0.3 to 0.1) | 2.2 (2.4) | 2.3 (2.7) | 0.0 (−0.2 to 0.2) | |
| Secondary outcomes | |||||||
| Physical complaints (0 (favourable) to 18) | 6.1 (3.2) | 6.2 (3.6) | 0.2 (−0.4 to 0.8) | 6.2 (3.2) | 6.4 (3.4) | −0.2 (−0.9 to 0.4) | |
| Daily activity (13 to 52 (favourable)) | 33.5 (6.9) | 30.9 (8.0) | 1.6 (0.6 to 2.7) | 33.1 (7.3) | 31.5 (7.7) | 1.0 (−0.2 to 2.2) | |
| Fear of falling (10 (favourable) to 40) | 16.5 (6.1) | 17.9 (7.9) | −2.5 (−4.0 to −1.0) | 16.1 (5.7) | 17.6 (7.3) | −1.9 (−3.3 to −0.5) | |
| Mental health (5 to 30 (favourable)) | 22.0 (5.3) | 22.2 (5.3) | −0.7 (−1.7 to 0.3) | 22.0 (4.8) | 21.9 (5.4) | −0.1 (−1.0 to 0.8) | |
| Social functioning (2 (favourable) to 12) | 6.4 (2.0) | 6.5 (1.9) | −0.3 (−0.7 to 0.1) | 6.4 (1.9) | 6.3 (2.0) | 0.0 (−0.4 to 0.4) | |
*
As assessed by multiple linear regression analyses.
†
This had moderate negative skewness, so multiple regression analyses were performed on transformed versions of this measure (square root).